Overview

Hydroxypropylmethylcellulose 0.3% and Sodium Hyaluronate 0.18% for Ocular Surface Disease in Glaucoma

Status:
Unknown status
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
To study effect of hydroxypropylmethylcellulose 0.3% and sodium hyaluronate 0.18% in the treatment of ocular surface disease in glaucoma patients.
Phase:
N/A
Details
Lead Sponsor:
Mahidol University
Treatments:
Hyaluronic Acid